Analyst Lee holds a virtual meeting with CEO Fischer and CFO Rubinstein on December 13 hosted by Truist.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADVM:
- Adverum Biotechnologies price target lowered to $16 from $20 at Mizuho
- Adverum Biotechnologies Advances Ixo-vec Gene Therapy Trials
- Adverum Biotechnologies reports results of two trials of Ixo-vec in AMD
- Adverum Biotechnologies price target lowered to $10 from $12 at RBC Capital
- Is ADVM a Buy, Before Earnings?